NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor-Reference-Cited by-同舟云学术

NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor

Published:2016-01-05 Issue:6 Volume:7 Page:6774-6789
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Brand Caroline¹,Schliemann Christoph¹,Ring Janine¹,Kessler Torsten¹,Bäumer Sebastian¹,Angenendt Linus¹,Mantke Verena¹,Ross Rebecca¹,Hintelmann Heike¹,Spieker Tilmann²,Wardelmann Eva²,Mesters Rolf M.¹,Berdel Wolfgang E.¹,Schwöppe Christian¹

Affiliation:

1. Department of Medicine A, Hematology, Oncology and Pneumology, University of Muenster, Albert-Schweitzer-Campus 1, D-48129 Muenster, Germany

2. Gerhard-Domagk Institute for Pathology, University of Muenster, Albert-Schweitzer-Campus 1, D-48129 Muenster, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process;Cancer Gene Therapy;2023-06-30

2. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer;Biomarker Research;2023-06-06

3. Simple and efficient protocol to isolate and culture brain microvascular endothelial cells from newborn mice;Frontiers in Cellular Neuroscience;2022-10-13

4. The Evolution of Safe and Effective Coaguligands for Vascular Targeting and Precision Thrombosis of Solid Tumors and Vascular Malformations;Biomedicines;2021-07-04

5. The Emerging Roles of Pericytes in Modulating Tumor Microenvironment;Frontiers in Cell and Developmental Biology;2021-06-11